GSK on NicoWater
This article was originally published in The Tan Sheet
Executive Summary
Nicorette and Nicoderm marketer "urges FDA to advise QT5 that it must immediately cease distribution and marketing" of its nicotine-containing beverage NicoWater as an OTC homeopathic product in recent comments. Claims in radio advertising and labeling that NicoWater "relieves the symptoms of tobacco cravings" render the product an unapproved new drug, the letter states. GSK also laments that FDA's failure to take action against the product has allowed QT5 to arrange for NicoWater to be sold through Rite Aid and Eckerd stores, and made it easier for consumers to purchase the product over the Internet. The comments follow a citizen petition objecting to the sale of NicoWater as an OTC homeopathic product, filed by the NRT marketer in March (1"The Tan Sheet" April 7, 2003, p. 7)...
You may also be interested in...
Nicowater OTC Homeopathic Remedy Classification Illegal – GSK
QT5's Nicowater nicotine beverage cannot legally be marketed as an over-the-counter homeopathic product because it contains "too great a concentration of nicotine," GSK asserts in a March 21 1citizen petition filed by Washington, D.C. law firm Ropes & Gray
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.